NDC codes

466581 NDC codes with hospital pricing data in the network.

• NDC 63323-0487-07 — Lidocaine-EPI *PF* Inj 1%-1:200,000 30 mL (UD) (102 hospitals, 909–1,215 samples)
• NDC 143959425 — LIDOCAINE (PF) 20 MG/ML (2 %) INJECTION SOLUTION (99 hospitals, 809–1,214 samples)
• NDC 24208-0555-55 — BACITRACIN-POLYMYXIN B 500-10000 UNIT/GM OP OINT (291 hospitals, 1,187–1,214 samples)
• NDC 25021011482 — CIPROFLOXACIN 200 MG/100 ML IN 5 % DEXTROSE INTRAVENOUS PIGGYBACK (152 hospitals, 143–1,214 samples)
• NDC 66794020741 — AMPICILLIN-SULBACTAM 3 GRAM SOLUTION FOR INJECTION (113 hospitals, 251–1,214 samples)
• NDC 66794020702 — AMPICILLIN-SULBACTAM 3 GRAM SOLUTION FOR INJECTION (69 hospitals, 251–1,214 samples)
• NDC 66794020641 — AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION (79 hospitals, 251–1,214 samples)
• NDC 55150011610 — AMPICILLIN-SULBACTAM 1.5 GRAM SOLUTION FOR INJECTION (59 hospitals, 251–1,214 samples)
• NDC 43598026525 — propofol 200 mg / 20 mL PREMIX (61 hospitals, 1,177–1,213 samples)
• NDC 55513019001 — NEULASTA 6 MG/0.6ML SC SOSY (508 hospitals, 403–1,213 samples)
• NDC 00536-1098-08 — melatonin 5 mg Tab (12 hospitals, 1,105–1,213 samples)
• NDC 58160-0976-20 — MENINGOC B OMV 0.5MLVACC (236 hospitals, 519–1,212 samples)
• NDC 70436-0127-40 — iopamidol 76% Inj (Isovue 370) (IV) (22 hospitals, 951–1,212 samples)
• NDC 25021031910 — dilTIAZem 5 mg/mL intravenous solution (115 hospitals, 960–1,212 samples)
• NDC 55150020200 — PANTOPRAZOLE SODIUM FOR IV SOLN 40 MG (BASE EQUIV) (271 hospitals, 464–1,211 samples)
• NDC 68516521402 — ALBUTEIN 5 % IV SOLN (313 hospitals, 725–1,211 samples)
• NDC 409379519 — Ketorolac Tromethamine IM Inj 30 MG/ML,Ketorolac Tromethamine Inj 30 MG/ML (42 hospitals, 770–1,211 samples)
• NDC 55513-206-01 — BEVACIZUMAB-AWWB 100 MG/4ML IV SOLN (129 hospitals, 1,184–1,211 samples)
• NDC 62332062702 — GLYCOPYRROLATE 0.2 MG/ML INJECTION SOLUTION (43 hospitals, 140–1,211 samples)
• NDC 78112-0011-06 — Benzocaine-Menthol 6 mg-10 mg Lozenge #18 (134 hospitals, 1,138–1,210 samples)
• NDC 60505614600 — CEFEPIME HCL FOR INJ 1 GM (352 hospitals, 121–1,210 samples)
• NDC 00023608210 — INFED 50 MG/ML IJ SOLN (319 hospitals, 121–1,210 samples)
• NDC 00409338511 — PIPERACILLIN-TAZOBACTAM 3.375 GRAM INTRAVENOUS SOLUTION (94 hospitals, 121–1,210 samples)
• NDC 00182-1692-33 — Tetrahydrozoline Ophth Soln 0.05% 15 mL (20 hospitals, 1,147–1,210 samples)
• NDC 00536-1064-01 — docusate sodium 250 mg Cap (10 hospitals, 1,147–1,210 samples)
• NDC 63323065100 — adenosine 3 mg/mL intravenous solution (130 hospitals, 121–1,210 samples)
• NDC 55150-0307-01 — Acetaminophen (32 hospitals, 1,201–1,210 samples)
• NDC 25021-0244-10 — Bortezomib Inj 2.5 mg/mL (VIAL)(SubQ) (50 hospitals, 1,101–1,209 samples)
• NDC 00029-6049-59 — amoxicillin 400 mg/5 mL Oral Liq 5 mL (11 hospitals, 1,127–1,208 samples)
• NDC 264315511 — cefTRIAXone in dextrose 2 gram/50 mL Piggyback 1 Each BAG (92 hospitals, 515–1,208 samples)
• NDC 25021082010 — METHYLPREDNISOLONE ACETATE 40 MG/ML SUSPENSION FOR INJECTION (39 hospitals, 596–1,208 samples)
• NDC 781320885 — Ceftriaxone Sodium For Inj 1 GM (77 hospitals, 766–1,207 samples)
• NDC 00048-1040-13 — levothyroxine 50 mcg Tab (13 hospitals, 1,126–1,207 samples)
• NDC 00407-1412-34 — IOHEXOL 240 MG IODINE/ML IV SOLN 150 ML BTL (39 hospitals, 955–1,207 samples)
• NDC 409471342 — LIDOCAINE (PF) 10 MG/ML (1 %) INJECTION SOLUTION (26 hospitals, 919–1,207 samples)
• NDC 60505-6230-04 — Paclitaxel Protein-Bound Inj 5 mg/mL (VIAL)(IV) (64 hospitals, 990–1,206 samples)
• NDC 00071-4259-03 — INJECTION, DIPHENHYDRAMINE HCL, UP TO 50 MG (10 hospitals, 873–1,206 samples)
• NDC 00023392102 — ONABOTULINUMTOXINA 200 UNITS RECON SOLN (139 hospitals, 279–1,206 samples)
• NDC 77333093410 — thiamine mononitrate (vitamin B1) 100 mg tablet (250 hospitals, 962–1,205 samples)
• NDC 77333093810 — CYANOCOBALAMIN TAB 1000 MCG (114 hospitals, 962–1,205 samples)
• NDC 00469-9400-00 — UNCLASSIFIED DRUGS (4 hospitals, 988–1,204 samples)
• NDC 0054350049 — LIDOCAINE HCL 2 % MUCOSAL SOLUTION (70 hospitals, 304–1,204 samples)
• NDC 0143932801 — BUPIVACAINE HCL 0.25 % (2.5 MG/ML) INJECTION SOLUTION (21 hospitals, 304–1,204 samples)
• NDC 0143933010 — BUPIVACAINE 0.25 % (2.5 MG/ML) INJECTION SOLUTION (PF OR NON-PF) (SO) (25 hospitals, 304–1,204 samples)
• NDC 0143957701 — LIDOCAINE 10 MG/ML (1 %) INFUSION (ANESTHESIA ONLY) (SO) (37 hospitals, 304–1,204 samples)
• NDC 0143957710 — LIDOCAINE 10 MG/ML (1 %) INFUSION (ANESTHESIA ONLY) (SO) (37 hospitals, 304–1,204 samples)
• NDC 0264180031 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (69 hospitals, 304–1,204 samples)
• NDC 0264180032 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (67 hospitals, 304–1,204 samples)
• NDC 0338004931 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (61 hospitals, 304–1,204 samples)
• NDC 0338004938 — SODIUM CHLORIDE 0.9 % INTRAVENOUS SOLUTION (62 hospitals, 304–1,204 samples)